(Q33395436)

26 July 2017

1 reference

title

Occult hepatitis C: how convincing are the current data? (English)

1 reference

26 July 2017

1 reference

1

Martin-Walter Welker

0 references

Stefan Zeuzem

series ordinal

2

object named as

Stefan Zeuzem

1 reference

26 July 2017

Martin-Walter Welker

1

1 reference

PubMed ID

19105211

26 July 2017

language of work or name

English

0 references

publication date

1 February 2009

1 reference

26 July 2017

1 reference

26 July 2017

49

1 reference

26 July 2017

2

1 reference

26 July 2017

665-675

1 reference

Ultracentrifugation of Serum Samples Allows Detection of Hepatitis C Virus RNA in Patients with Occult Hepatitis C

26 July 2017

1 reference

Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C.

21 January 2018

1 reference

HBV, HCV, and TTV detection by in situ polymerase chain reaction could reveal occult infection in hepatocellular carcinoma: comparison with blood markers

21 January 2018

1 reference

Evidence for viral persistence in patients who test positive for anti-hepatitis C virus antibodies and have normal alanine aminotransferase levels

21 January 2018

1 reference

Comparison of hepatitis C virus RNA detection in plasma, whole blood and peripheral blood mononuclear cells of patients with occult hepatitis C virus infection

21 January 2018

1 reference

Detection of hepatitis C virus (HCV) RNA in the liver of healthy, anti-HCV antibody-positive, serum HCV RNA-negative patients with normal alanine aminotransferase levels

21 January 2018

1 reference

Hepatitis C virus replicates in the liver of patients who have a sustained response to antiviral treatment

21 January 2018

1 reference

Hepatitis C virus replicates in peripheral blood mononuclear cells of patients with occult hepatitis C virus infection

21 January 2018

1 reference

Occult hepatitis C virus infection in patients in whom the etiology of persistently abnormal results of liver-function tests is unknown

21 January 2018

1 reference

Comparative study on the clinical and virological characteristics among patients with single occult hepatitis B virus (HBV), single occult hepatitis C virus (HCV) and occult HBV and HCV dual infection

21 January 2018

1 reference

Comparative study between occult hepatitis C virus infection and chronic hepatitis C.

21 January 2018

1 reference

Effect of anti-viral therapy for occult hepatitis C virus infection

21 January 2018

1 reference

Virus-specific T-cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection

21 January 2018

1 reference

Occult hepatitis C virus infection: a new form of hepatitis C

21 January 2018

1 reference

Replication of hepatitis C virus

21 January 2018

1 reference

Specific detection of hepatitis C virus minus strand RNA in hematopoietic cells

21 January 2018

1 reference

Detection and Analysis of Hepatitis C Virus Sequences in Cerebrospinal Fluid

21 January 2018

1 reference

Detection of hepatitis C virus sequences in brain tissue obtained in recurrent hepatitis C after liver transplantation.

21 January 2018

1 reference

Differences in hypervariable region 1 quasispecies of hepatitis C virus in human serum, peripheral blood mononuclear cells, and liver

21 January 2018

1 reference

Hepatitis C virus-RNAs in plasma and in peripheral blood mononuclear cells of hemophiliacs with chronic hepatitis C: evidence for viral replication in peripheral blood mononuclear cells

21 January 2018

1 reference

Search for hepatitis C virus negative-strand RNA sequences and analysis of viral sequences in the central nervous system: evidence of replication

21 January 2018

1 reference

Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy

21 January 2018

1 reference

Reemergence of hepatitis C virus after 8.5 years in a patient with hypogammaglobulinemia: evidence for an occult viral reservoir

21 January 2018

1 reference

Hepatitis C virus persistence after spontaneous or treatment-induced resolution of hepatitis C.

21 January 2018

1 reference

Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy

21 January 2018

1 reference

Antagonistic expression of hepatitis C virus and alpha interferon in lymphoid cells during persistent occult infection.

21 January 2018

1 reference

Cryptogenic chronic liver disease and serum or liver hepatitis B virus markers. Their possible correlations and etiologic significance

21 January 2018

1 reference

Pathological and virological findings in patients with persistent hypertransaminasaemia of unknown aetiology

21 January 2018

1 reference

Hepatitis C virus is not recoverable from liver tissue in cryptogenic cirrhosis: failure to identify hepatitis C virus-RNA using reverse transcription-mediated polymerase chain reaction

21 January 2018

1 reference

Occult Hepatitis C Virus Infection Revisited with Ultrasensitive Real-Time PCR Assay

21 January 2018

1 reference

Occult Hepatitis C Virus Infection among Hemodialysis Patients

21 January 2018

1 reference

Surreptitious hepatitis C virus (HCV) infection detected in the majority of patients with cryptogenic chronic hepatitis and negative HCV antibody tests.

21 January 2018

1 reference

Hepatitis C virus (HCV) occult infection or occult HCV RNA detection?

21 January 2018

1 reference

Direct comparison of hepatitis C virus genotypes tested by INNO-LiPA HCV II and TRUGENE HCV genotyping methods

21 January 2018

1 reference

Serum versus intrahepatic HCV RNA and liver histology

21 January 2018

1 reference

Mathematical modeling of primary hepatitis C infection: noncytolytic clearance and early blockage of virion production

21 January 2018

1 reference

Hepatitis C virus dynamics in vivo: effect of ribavirin and interferon alfa on viral turnover

21 January 2018

1 reference

Intrahepatic hepatitis C viral RNA status of serum polymerase chain reaction-negative individuals with histological changes on liver biopsy

21 January 2018

1 reference

Hepatic HCV RNA before and after treatment with interferon alone or combined with ribavirin

21 January 2018

1 reference

Long term histological improvement and clearance of intrahepatic hepatitis C virus RNA following sustained response to interferon-ribavirin combination therapy in liver transplanted patients with hepatitis C virus recurrence

21 January 2018

1 reference

Clearance of hepatitis C virus RNA from the peripheral blood mononuclear cells of blood donors who spontaneously or therapeutically control their plasma viremia

21 January 2018

1 reference

Detection of hepatitis C virus in paraffin-embedded liver biopsies of patients negative for viral RNA in serum

21 January 2018

1 reference

Histological improvement of chronic liver disease after spontaneous serum hepatitis C virus clearance

21 January 2018

1 reference

Clinical significance of intrahepatic hepatitis C virus levels in patients with chronic HCV infection

21 January 2018

1 reference

Long term clinical outcome of chronic hepatitis C patients with sustained virological response to interferon monotherapy.

21 January 2018

1 reference

Long-term follow-up after successful interferon therapy of acute hepatitis C.

21 January 2018

1 reference

HCV recovery from peripheral blood mononuclear cell culture supernatants derived from HCV–HIV co‐infected haemophilic patients with undetectable HCV viraemia

21 January 2018

1 reference

Mitogen-induced upregulation of hepatitis C virus expression in human lymphoid cells

21 January 2018

1 reference

Hepatic and extrahepatic hepatitis C virus replication in relation to response to interferon therapy

21 January 2018

1 reference

Replication of hepatitis C virus in peripheral blood mononuclear cells. Effect of alpha-interferon therapy

21 January 2018

1 reference

Antibody testing and RT-PCR results in hepatitis C virus (HCV) infection: HCV-RNA detection in PBMC of plasma viremia-negative HCV-seropositive persons

21 January 2018

1 reference

Detection of hepatitis C virus RNA in serum and peripheral blood mononuclear cells in patients with chronic hepatitis C treated with interferon alpha

21 January 2018

1 reference

Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C.

21 January 2018

1 reference

Virus elimination and histologic improvement in patients with chronic hepatitis C treated with interferon alpha

21 January 2018

1 reference

Eradication of hepatitis C virus RNA after alpha-interferon therapy

21 January 2018

1 reference

Evidence that clearance of hepatitis C virus RNA after alpha-interferon therapy in dialysis patients is sustained after renal transplantation

21 January 2018

1 reference

Prediction of relapses after interferon-alpha therapy by hepatitis C virus RNA in peripheral blood mononuclear cells

21 January 2018

1 reference

Assessment, by transcription-mediated amplification, of virologic response in patients with chronic hepatitis C virus treated with peginterferon alpha-2a

21 January 2018

1 reference

Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection

21 January 2018

1 reference

Interaction between the hepatitis C virus and the immune system

21 January 2018

1 reference

Kinetics of CD4+ and CD8+ Memory T-Cell Responses during Hepatitis C Virus Rechallenge of Previously Recovered Chimpanzees

21 January 2018

1 reference

Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C

21 January 2018

1 reference

HCV Persistence and Immune Evasion in the Absence of Memory T Cell Help

21 January 2018

1 reference

Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection

21 January 2018

1 reference

Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C

21 January 2018

1 reference

Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C.

21 January 2018

1 reference

Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection

21 January 2018

1 reference

Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo

21 January 2018

1 reference

Immunology of hepatitis B virus and hepatitis C virus infection

21 January 2018

1 reference

Lymphocyte reactivity to hepatitis C virus (HCV) antigens shows evidence for exposure to HCV in HCV-seronegative spouses of HCV-infected patients

21 January 2018

1 reference

Hepatitis C virus-specific cytolytic T lymphocyte and T helper cell responses in seronegative persons

21 January 2018

1 reference

Detection of Anti-GOR Antibodies in HCV Infection

21 January 2018

1 reference

Serum Immunoglobulin G Antibodies to the GOR Autoepitope Are Present in Patients with Occult Hepatitis C Virus (HCV) Infection despite Lack of HCV-Specific Antibodies

21 January 2018

1 reference

Antinuclear antibodies (ANA) in chronic hepatitis C virus infection: correlates of positivity and clinical relevance

21 January 2018

1 reference

Occult hepatitis C virus infection in type II mixed cryoglobulinaemia

21 January 2018

1 reference

Association between mixed cryoglobulinemia, translocation (14;18), and persistence of occult HCV lymphoid infection after treatment

21 January 2018

1 reference

Impaired Hepatitis C Virus-Specific T Cell Responses and Recurrent Hepatitis C Virus in HIV Coinfection

21 January 2018

1 reference

Reactivation of hepatitis C virus after chemotherapy for colon cancer

21 January 2018

1 reference

Risk factors for cytomegalovirus, hepatitis B and C virus reactivation after bone marrow transplantation

21 January 2018

1 reference

Occult hepatitis C virus infection during an outbreak in a hemodialysis unit in Thailand

21 January 2018

1 reference

HCV persistence: cure is still a four letter word

21 January 2018

1 reference

Hepatocellular carcinoma in a patient with liver cirrhosis associated with negative serum HCV tests but positive liver tissue HCV RNA.

21 January 2018

1 reference

21 January 2018

1 reference

The effects of HCV infection and management on health-related quality of life

21 January 2018

1 reference

Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C.

21 January 2018

1 reference

Antiviral therapy for cirrhotic hepatitis C: association with reduced hepatocellular carcinoma development and improved survival

21 January 2018

1 reference

Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: a retrospective study

21 January 2018

1 reference

Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis.

21 January 2018

1 reference

Estimating the impact of hepatitis C virus therapy on future liver-related morbidity, mortality and costs related to chronic hepatitis C.

21 January 2018

1 reference

Long-term evolution of serum and liver viral markers in patients treated for chronic hepatitis C and sustained response

21 January 2018

1 reference

Persistent hepatitis C viremia predicts late relapse after sustained response to interferon-alpha in chronic hepatitis C. TriVeneto Viral Hepatitis Group

21 January 2018

1 reference

Long-term course of interferon-treated chronic hepatitis C.

21 January 2018

1 reference

10-Year follow-up after interferon-alpha therapy for chronic hepatitis C.

21 January 2018

1 reference

Long-term follow-up of chronic hepatitis C patients with sustained virological response to alpha-interferon

21 January 2018

1 reference

Histological and virological long-term outcome in patients treated with interferon-alpha2b and ribavirin for chronic hepatitis C.

21 January 2018

1 reference

Long term follow-up of patients with chronic hepatitis C treated with interferon alpha

21 January 2018

1 reference

Long-term beneficial effects in sustained responders to interferon-alfa therapy for chronic hepatitis C.

21 January 2018

1 reference

Long-term follow up of chronic hepatitis C patients after alpha-interferon treatment: a functional study

21 January 2018

1 reference

Treatment of chronic hepatitis C in injecting drug users: 5 years' follow-up

21 January 2018

1 reference

Effects of alpha interferon induction plus ribavirin with or without amantadine in the treatment of interferon non-responsive chronic hepatitis C: a randomised trial

21 January 2018

1 reference

Virus genotype 1b and long-term response to interferon alpha monotherapy in children with chronic hepatitis C.

21 January 2018

1 reference

Long-term liver histology improvement in patients with chronic hepatitis C and sustained response to interferon.

21 January 2018

1 reference

Late relapse in chronic hepatitis C after sustained viral response to interferon and ribavirin

21 January 2018

1 reference

Long-term clinical and virological outcomes of chronic hepatitis C after successful interferon therapy

21 January 2018

1 reference

Long-term outcomes of chronic hepatitis C patients with sustained virological response at 6 months after the end of treatment

21 January 2018

1 reference

Long-term follow-up of previous hepatitis C virus positive nonresponders to interferon monotherapy successfully retreated with combination therapy: are they really cured?

21 January 2018

1 reference

Sustained virological response rates and durability of the response to interferon-based therapies in hepatitis C patients treated in the clinical setting

21 January 2018

1 reference

Long-term follow-up of chronic hepatitis C patients with sustained virological response to various forms of interferon-based anti-viral therapy

21 January 2018

1 reference

Efficacy and long-term follow up of combination therapy with interferon alpha and ribavirin for chronic hepatitis C in Korea

21 January 2018

1 reference

Long-term follow-up of the hepatitis C HENCORE cohort: response to therapy and occurrence of liver-related complications

21 January 2018

1 reference

Antiviral therapy for chronic hepatitis C in patients with inherited bleeding disorders: an international, multicenter cohort study

21 January 2018

1 reference

Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.

21 January 2018

1 reference

Benefit of sustained virological response to combination therapy on graft survival of liver transplanted patients with recurrent chronic hepatitis C.

21 January 2018

1 reference

Fatal liver disease despite sustained eradication of recurrent hepatitis C virus requiring liver retransplantation

21 January 2018

1 reference

Sustained virologic response to therapy of recurrent hepatitis C after liver transplantation is related to early virologic response and dose adherence

21 January 2018

1 reference

Long-term outcome of chronic hepatitis C virus infection in primary hypogammaglobulinaemia

21 January 2018

1 reference

Hepatic hepatitis C virus RNA as a predictor of a long-term response to interferon-alpha therapy

21 January 2018

1 reference

High incidence of hepatitis B infections among chronic hepatitis cases of unknown aetiology

21 January 2018

1 reference

7 January 2021

Hepatic immunohistochemical staining with a monoclonal antibody against HCV-E2 to evaluate antiviral therapy and reinfection of liver grafts in hepatitis C viral infection

1 reference

7 January 2021

671 REACTIVATION OF HEPATITIS C IN A PATIENT WITH ADVANCED HUMAN IMMUNODEFICIENCY VIRUS INFECTION

1 reference

7 January 2021

Hepatocellular carcinoma (case 2-1996)

1 reference

7 January 2021

Hepatitis C virus eradication in intravenous drug users maintained with subcutaneous naltrexone implants

1 reference

7 January 2021

Interferon therapy in hemodialysis patients with chronic hepatitis C: study of tolerance, efficacy and post-transplantation course

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.22706

1 reference

26 July 2017

1 reference

PubMed ID

19105211